G. A. Glendenning

Publication List Details

Period

2005 - 2005

Number

5

Co-Authors

The significance of skeletal-related events for the health-related quality of life of patients with metastatic prostate cancer (2005)

Weinfurt, K. P., Li, Y., Castel, L. D., Saad, F., Timbie, J. W., Glendenning, G. A., ...

Background: We examined the clinical relevance of skeletal-related events (SREs) for health state preferences, pain and health-related quality of life in patients with advanced prostate cancer and a...

Quality-adjusted survival in a crossover trial of letrozole versus tamoxifen in postmenopausal women with advanced breast cancer (2005)

Irish, W., Sherrill, B., Cole, B., Gard, C., Glendenning, G. A., Mouridsen, H.

Background: Results from a phase III study of postmenopausal women with advanced breast cancer demonstrated longer time to disease progression for patients taking letrozole versus tamoxifen. This...

The significance of skeletal-related events for the health-related quality of life of patients with metastatic prostate cancer (2005)

Weinfurt, K. P., Li, Y., Castel, L. D., Saad, F., Timbie, J. W., Glendenning, G. A., ...

Background: We examined the clinical relevance of skeletal-related events (SREs) for health state preferences, pain and health-related quality of life in patients with advanced prostate cancer and a...

Quality-adjusted survival in a crossover trial of letrozole versus tamoxifen in postmenopausal women with advanced breast cancer (2005)

Irish, W., Sherrill, B., Cole, B., Gard, C., Glendenning, G. A., Mouridsen, H.

Background: Results from a phase III study of postmenopausal women with advanced breast cancer demonstrated longer time to disease progression for patients taking letrozole versus tamoxifen. This...

Dose equivalence and bronchoprotective effects of salmeterol and salbutamol in asthma

Higham, M. A., Sharara, A. M., Wilson, P., Jenkins, R. J., Glendenning, G. A., Ind, P. W.

BACKGROUND: Salbutamol is the most widely prescribed short acting beta 2 agonist and salmeterol is the first long acting inhaled beta 2 agonist. The dose equivalence of salmeterol and salbutamol is...